Treasurys Turn Higher… And Novo Sinks After Trial Failure 7/31/26
U.S. Treasurys popping to end the week as the 2 Year hits a near two-decade high and the 10 Year reaches highs not seen since January 2025. The traders break down the reason behind the surge and if this could affect the next Fed rate decision. Then, Novo Nordisk tumbling after a heart medicine trial failure. Mizuho…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from CNBC's "Fast Money"
See all episodes →Meta’s Rally Keeps Rocking… And A Major AI Safety Warning 9/24/26
U.S. 10-Year Yield Hits 19-Year High… And The Ripple Effects From Meta’s Muse 9/23/26
Meta’s Muse Ripple Effects… And A Coiled Spring In Google 9/22/26
Similar episodes from other shows
More like CNBC's "Fast Money" →
CNBC Fast Money Special Edition 7/12/22
New Highs for Alphabet, Amazon & Microsoft
Do Rising Interest Rates Finally Matter? – Ep. 323
How The Crisis Nearly Blew Up One Of The World’s Safest Trades
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.